All inoculum suspensions were prepared in sterile saline solution and turbidity was adjusted to a 1 McFarland scale by densitometer (DEN-1 densitometer, Biosan). This inoculum was diluted 1:100 in supplemented RPMI medium to achieve a final concentration of 0.5–2.5 × 105 CFU/mL.
AgNP and KTZ solutions were prepared using dimethyl sulfoxide (DMSO) as solvent (final concentration ≤ 1%) and RPMI medium as diluents. A twofold dilution serial of the drugs was performed to obtain a final concentration range from 4 to 0.008 mg/L. The microtiter plates with 96 U wells (Greiner bio-One, Buenos Aires, Argentina) were incubated for 3 days at 32 °C.
MIC for AgNP solution was determined by visual reading of growth inhibition at two endpoints: MIC-2 as the lowest concentration capable of inhibiting ≥ 50% growth as compared with the AgNP-free growth-control well and MIC-0 as the lowest concentration that completely inhibit yeast growth. For KTZ, the MIC endpoint was MIC-2 (Clinical and Laboratory Standards Institute 2008 ).